The global fish oil market is projected to witness remarkable growth, surging from USD 10.4 billion in 2025 to USD 24.6 billion by 2035 at a compound annual growth rate (CAGR) of 9.0%. This growth is driven by the increasing recognition of omega-3 fatty acids’ health benefits, particularly for heart, brain, and joint wellness, alongside rising applications in pharmaceuticals, dietary supplements, functional foods, pet nutrition, and aquaculture.
Fish oil, rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), has emerged as a staple ingredient across health and nutrition segments. Advances in molecular distillation and ultra-purification technologies are enabling manufacturers to provide high-quality, potent formulations, especially for pharmaceutical-grade and infant nutrition applications.
Get Exclusive Access To Data Tables, Market Sizing Dashboards, And Analyst Insights. Request Sample Report!
Key Market Insights
- Market Value (2025): USD 10.4 billion
- Forecast Value (2035): USD 24.6 billion
- CAGR (2025-2035): 9.0%
- Leading Product (2025): Salmon Oil (45% market share)
- Top Processing Segment: Refined Fish Oil (40% market share)
- Market Leader: Omega Protein Corporation (15% global share)
- Fastest-Growing Region: China (6.3% CAGR)
Salmon oil is expected to lead the product segment, accounting for 45% of the market in 2025, due to its superior EPA and DHA content supporting cardiovascular and cognitive health. Refined fish oil dominates the processing segment, offering purity, stability, and bioavailability essential for nutraceutical and infant formula applications.
Within dietary supplements, fish oil captures 38% of the market, driven by growing awareness of heart, brain, and joint health benefits. Feed-grade fish oil, used primarily in aquaculture, is expanding its influence, accounting for 15% of the market share.
Regional Market Dynamics
- China: Rapid expansion of pharmaceutical-grade omega-3 APIs is fueling market growth, driven by local companies like Fuyuan Aquatic and Zhejiang NBT Marine Biopharmaceutical, meeting both domestic and export demand.
- United States: High-potency omega-3 concentrates for clinical nutrition, functional foods, and premium supplements are trending, with top players like Omega Protein Corporation, DSM (USA), and Archer Daniels Midland leading the innovation.
- Norway: Salmon oil producers, including GC Rieber VivoMega and Epax, are emphasizing omega-3 stability and oxidation control for longer shelf life and higher bioavailability.
Industry Drivers and Opportunities
- Pharmaceutical-Grade Omega-3: Prescription omega-3 formulations like Vascepa® and Lovaza® are driving demand for ultra-purified fish oils with ≥85% EPA/DHA content.
- Sustainable Raw Material Sourcing: Wild-caught anchovies and sardines face supply volatility due to climate and fishing quotas, prompting diversification into seafood by-products and alternative sources like krill and algae.
- Aquaculture and Livestock Nutrition: Rising demand for nutrient-rich fish feed and omega-3-enriched livestock products is boosting market opportunities.
- Regulatory Compliance: Stricter limits on heavy metals, dioxins, and PCBs by FDA, EFSA, and GOED are promoting high-purity, certified fish oil products.
Leading Players
The global fish oil market exhibits moderate consolidation with established leaders:
- DSM (Netherlands)
- BASF SE (Germany)
- Croda International Plc (UK)
- GC Rieber VivoMega (Norway)
- Pelagia AS (Norway)
- FF Skagen A/S (Denmark)
- TASA (Peru)
- Omega Protein Corporation (USA)
- Copeinca ASA (Peru)
- Golden Omega (Chile)
Emerging players such as Marvesa Holding N.V. and Colpex International are gaining traction in niche markets like pharmaceutical-grade oils and aquafeed. Entry barriers include stringent sustainability standards, volatile raw material availability, and high capital investments in refining and logistics infrastructure.
Subscribe for Year-Round Insights → Stay ahead with quarterly and annual data updates.
Recent Developments
- Omega Protein collaborated with a biotech firm in May 2025 to enhance lipid purification for clinical-grade EPA/DHA nutraceuticals.
- Corpesca acquired Pesquera Diamante’s assets, consolidating Peru’s raw material base and expanding exports.
- Advanced enzymatic hydrolysis technology is being piloted to improve extraction efficiency and product stability across multiple manufacturers.
About Future Market Insights (FMI)
Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1,200 markets worldwide.
